Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

A mixed bag of counterintuitive results hinders trial interpretation, but experts still see actionable results.

Of the 518 hospitals that had at least 10 eligible discharges, only 11 of them prescribed SGLT2 inhibitors to more than half ...

American Heart Association Scientific Sessions 2024, Late Breaking Science Abstract 4170722 - A study testing a new nasal ...

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...

Sitting at your desk all day may put you at greater risk for heart disease — even if you work out in your spare time, ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

A new study by heart researchers at Intermountain Health in Salt Lake City finds that patients with heart disease, ...

Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...